<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: ChinaSecurities.com &#8211; China’s Massive Healthcare Initiative Provides Vast Opportunities for Investors</title>
	<atom:link href="http://blog.agoracom.com/2009/06/29/chinasecuritiescom-china%e2%80%99s-massive-healthcare-initiative-provides-vast-opportunities-for-investors/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.agoracom.com/2009/06/29/chinasecuritiescom-china%e2%80%99s-massive-healthcare-initiative-provides-vast-opportunities-for-investors/</link>
	<description>The Good Side of The Small-Cap, Micro-Cap Stock Market</description>
	<lastBuildDate>Thu, 19 Nov 2009 17:14:58 -0500</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: JC</title>
		<link>http://blog.agoracom.com/2009/06/29/chinasecuritiescom-china%e2%80%99s-massive-healthcare-initiative-provides-vast-opportunities-for-investors/comment-page-1/#comment-6098</link>
		<dc:creator>JC</dc:creator>
		<pubDate>Mon, 29 Jun 2009 20:23:26 +0000</pubDate>
		<guid isPermaLink="false">http://blog.agoracom.com/?p=2748#comment-6098</guid>
		<description>I was actually looking at Tianyin last week.   I believe that this is one of many Chinese companies in the health care sector that will be a huge beneficiary of this proposed bill. What was of particular interest to me was the compound annual growth rate in revenue from &#039;06 -&#039;08 of almost 60%.</description>
		<content:encoded><![CDATA[<p>I was actually looking at Tianyin last week.   I believe that this is one of many Chinese companies in the health care sector that will be a huge beneficiary of this proposed bill. What was of particular interest to me was the compound annual growth rate in revenue from &#8216;06 -&#8217;08 of almost 60%.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: leo polenta</title>
		<link>http://blog.agoracom.com/2009/06/29/chinasecuritiescom-china%e2%80%99s-massive-healthcare-initiative-provides-vast-opportunities-for-investors/comment-page-1/#comment-6097</link>
		<dc:creator>leo polenta</dc:creator>
		<pubDate>Mon, 29 Jun 2009 19:55:54 +0000</pubDate>
		<guid isPermaLink="false">http://blog.agoracom.com/?p=2748#comment-6097</guid>
		<description>as soon as I read point #5 I immediately realized that there is a huge market there for small cap companies looking to take advantage of chinas healthcare spending spree. I added the companies in your blog to my watch list, thanks George.</description>
		<content:encoded><![CDATA[<p>as soon as I read point #5 I immediately realized that there is a huge market there for small cap companies looking to take advantage of chinas healthcare spending spree. I added the companies in your blog to my watch list, thanks George.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Luck of the Irish</title>
		<link>http://blog.agoracom.com/2009/06/29/chinasecuritiescom-china%e2%80%99s-massive-healthcare-initiative-provides-vast-opportunities-for-investors/comment-page-1/#comment-6096</link>
		<dc:creator>Luck of the Irish</dc:creator>
		<pubDate>Mon, 29 Jun 2009 19:06:36 +0000</pubDate>
		<guid isPermaLink="false">http://blog.agoracom.com/?p=2748#comment-6096</guid>
		<description>There&#039;s another reason for looking at Chinese pharmaceuticals.  Those companies don&#039;t have to meet FDA requirements like they do stateside.  To bring a new product to market in the states takes a lot of time and money.  Less time, less money, bigger market in China.  Nuf said.  It&#039;s a sad commentary but I think the Chinese people will be human guinea pigs for the north american pharmaceuitcal market which is why those companies will grow.</description>
		<content:encoded><![CDATA[<p>There&#8217;s another reason for looking at Chinese pharmaceuticals.  Those companies don&#8217;t have to meet FDA requirements like they do stateside.  To bring a new product to market in the states takes a lot of time and money.  Less time, less money, bigger market in China.  Nuf said.  It&#8217;s a sad commentary but I think the Chinese people will be human guinea pigs for the north american pharmaceuitcal market which is why those companies will grow.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Eric</title>
		<link>http://blog.agoracom.com/2009/06/29/chinasecuritiescom-china%e2%80%99s-massive-healthcare-initiative-provides-vast-opportunities-for-investors/comment-page-1/#comment-6095</link>
		<dc:creator>Eric</dc:creator>
		<pubDate>Mon, 29 Jun 2009 19:04:55 +0000</pubDate>
		<guid isPermaLink="false">http://blog.agoracom.com/?p=2748#comment-6095</guid>
		<description>Very impressive, so far ahead of the herd on this one aspect of the Chinese market, if health care is to explode in the US&lt; i can only imagine the monies that will come into the Chinese health care sector. 

Interesting part about Tianyin is that it focuses on modernized forms of traditional Chinese medications and has an extensive and diverse product portfolio.

Definitely a stock to keep an eye on.</description>
		<content:encoded><![CDATA[<p>Very impressive, so far ahead of the herd on this one aspect of the Chinese market, if health care is to explode in the US&lt; i can only imagine the monies that will come into the Chinese health care sector. </p>
<p>Interesting part about Tianyin is that it focuses on modernized forms of traditional Chinese medications and has an extensive and diverse product portfolio.</p>
<p>Definitely a stock to keep an eye on.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
